325 related articles for article (PubMed ID: 3511098)
1. Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies.
Earnshaw W; Bordwell B; Marino C; Rothfield N
J Clin Invest; 1986 Feb; 77(2):426-30. PubMed ID: 3511098
[TBL] [Abstract][Full Text] [Related]
2. Proteins responsible for anticentromere activity found in the sera of patients with CREST-associated Raynaud's phenomenon.
Kremer L; Alvaro-Gracia JM; Ossorio C; Avila J
Clin Exp Immunol; 1988 Jun; 72(3):465-9. PubMed ID: 3048807
[TBL] [Abstract][Full Text] [Related]
3. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
Vázquez-Abad D; Grodzicky T; Senécal JL
Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829
[TBL] [Abstract][Full Text] [Related]
4. Anticentromere autoantibodies. Evaluation of an ELISA using recombinant fusion protein CENP-B as antigen.
Vázquez-Abad D; Wallace S; Senécal JL; Joyal F; Roussin A; Earnshaw WC; Rothfield N
Arthritis Rheum; 1994 Feb; 37(2):248-52. PubMed ID: 8129780
[TBL] [Abstract][Full Text] [Related]
5. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA.
Mahler M; You D; Baron M; Taillefer SS; Hudson M; ; Fritzler MJ
Clin Chim Acta; 2011 Oct; 412(21-22):1937-43. PubMed ID: 21756890
[TBL] [Abstract][Full Text] [Related]
6. The heterogeneity of anticentromere antibodies in immunoblotting analysis.
Muro Y; Sugimoto K; Okazaki T; Ohashi M
J Rheumatol; 1990 Aug; 17(8):1042-7. PubMed ID: 2213779
[TBL] [Abstract][Full Text] [Related]
7. New centromere autoantigens identified in systemic sclerosis using centromere protein microarrays.
Song G; Hu C; Zhu H; Wang L; Zhang F; Li Y; Wu L
J Rheumatol; 2013 Apr; 40(4):461-8. PubMed ID: 23418382
[TBL] [Abstract][Full Text] [Related]
8. [The clinical significance of anti-ENA antibodies and anticentromere antibody (ACA) in patients with sclerodermatous skin changes and Raynaud's phenomenon].
Uchida K; Kondo H; Kashiwazaki S
Ryumachi; 1984 Aug; 24(4):241-9. PubMed ID: 6334895
[No Abstract] [Full Text] [Related]
9. Cytogenetic survey in systemic sclerosis: correlation of aneuploidy with the presence of anticentromere antibodies.
Jabs EW; Tuck-Muller CM; Anhalt GJ; Earnshaw W; Wise RA; Wigley F
Cytogenet Cell Genet; 1993; 63(3):169-75. PubMed ID: 8387418
[TBL] [Abstract][Full Text] [Related]
10. Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies.
Kallenberg CG; Pastoor GW; Wouda AA; The TH
Ann Rheum Dis; 1982 Aug; 41(4):382-7. PubMed ID: 7051989
[TBL] [Abstract][Full Text] [Related]
11. Differential isotype recognition of two centromere associated polypeptides by immunoblotting in connective tissue disease.
McHugh NJ; James IE; Maddison PJ
Clin Exp Immunol; 1988 Jun; 72(3):457-64. PubMed ID: 3048806
[TBL] [Abstract][Full Text] [Related]
12. CENP-O, a protein localized at the centromere throughout the cell cycle, is a novel target antigen in systemic sclerosis.
Saito A; Muro Y; Sugiura K; Ikeno M; Yoda K; Tomita Y
J Rheumatol; 2009 Apr; 36(4):781-6. PubMed ID: 19286853
[TBL] [Abstract][Full Text] [Related]
13. Analysis of anticentromere autoantibodies using cloned autoantigen CENP-B.
Earnshaw WC; Machlin PS; Bordwell BJ; Rothfield NF; Cleveland DW
Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4979-83. PubMed ID: 2440036
[TBL] [Abstract][Full Text] [Related]
14. Anticentromere antibody: an immunological marker of a subset of systemic sclerosis.
Chorzelski TP; Jablonska S; Beutner EH; Blaszczyk M; Jarzabek-Chorzelska M; Kencka D; Krasny S; Kumar V; Tchórzewska A
Br J Dermatol; 1985 Oct; 113(4):381-9. PubMed ID: 3877519
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of anti-centromere antibody and anti-CENP-B antibody in sera of patients with primary biliary cirrhosis].
Onozuka Y; Shibata M; Yonezawa H; Terauti K; Miyachi K; Ueno Y
Rinsho Byori; 1996 Sep; 44(9):877-82. PubMed ID: 8911074
[TBL] [Abstract][Full Text] [Related]
16. [Raynaud's phenomenon and anticentromere antibodies].
Marquet Palomer R; Vilardell Tarrés M; Ordi Ros J
Med Clin (Barc); 1987 Nov; 89(17):721-4. PubMed ID: 3501051
[No Abstract] [Full Text] [Related]
17. Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma).
Conrad K; Stahnke G; Liedvogel B; Mehlhorn J; Barth J; Blasum C; Altmeyer P; Sönnichsen N; Frank KH
J Rheumatol; 1995 Jul; 22(7):1286-94. PubMed ID: 7562760
[TBL] [Abstract][Full Text] [Related]
18. [Anti-centromere antibody, biological marker of the CREST syndrome as distinct from scleroderma].
Rouquette-Gally AM; Stern MH; Prost AC; Abuaf N; Homberg JC; Combrisson A
Presse Med; 1985 Jul 13-20; 14(28):1497-500. PubMed ID: 2931679
[TBL] [Abstract][Full Text] [Related]
19. Proteomics characterization of CENP-B epitope in Moroccan scleroderma patients with anti-centromere autoantibodies.
Zian Z; Bennani Mechita M; Hamdouch K; Maamar M; Barakat A; Ghailani Nourouti N; El Aouad R; Valdivia MM; Arji N
Immunol Lett; 2020 May; 221():1-5. PubMed ID: 32057908
[TBL] [Abstract][Full Text] [Related]
20. A long-term longitudinal study of anticentromere antibodies.
Tramposch HD; Smith CD; Senecal JL; Rothfield N
Arthritis Rheum; 1984 Feb; 27(2):121-4. PubMed ID: 6607733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
